122 related articles for article (PubMed ID: 1122483)
1. Elevated IGA in carcinoma of the nasopharynx.
Wara WM; Wara DW; Phillips TL; Ammann AJ
Cancer; 1975 May; 35(5):1313-5. PubMed ID: 1122483
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.
Nemoto T; Han T; Minowada J; Angkur V; Chamberlain A; Dao L
J Natl Cancer Inst; 1974 Sep; 53(3):641-5. PubMed ID: 4606319
[No Abstract] [Full Text] [Related]
3. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
Bier J; Bitter K; Nicklisch U
J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
[TBL] [Abstract][Full Text] [Related]
4. General immunological status of nasopharyngeal carcinoma patients in Singapore.
Chan SH; Goh EH; Khor TH; Chew TS
IARC Sci Publ (1971); 1978; (20):495-501. PubMed ID: 215531
[TBL] [Abstract][Full Text] [Related]
5. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
Catalona WJ; Tarpley JL; Potvin C; Chretien PB
Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
[TBL] [Abstract][Full Text] [Related]
6. Immunologic reactivity in patients with nasopharyngeal carcinoma.
Hsu MM; Wang KR; Lynn TC; Hsieh T; Huang SC; Tu SM
Otolaryngol Head Neck Surg; 1980; 88(4):384-90. PubMed ID: 6821420
[TBL] [Abstract][Full Text] [Related]
7. Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value.
Desgranges C; de-The G
IARC Sci Publ (1971); 1978; (20):459-69. PubMed ID: 215528
[No Abstract] [Full Text] [Related]
8. Effect of levamisole on cell-mediated immune responses in patients with nasopharyngeal carcinoma.
Goh EH; Chan SH; Simons MJ
IARC Sci Publ (1971); 1978; (20):503-10. PubMed ID: 730200
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immunity, Epstein-Barr virus and nasopharyngeal carcinoma.
Levine PH; Lamelin JP; Stevens DA
IARC Sci Publ (1971); 1978; (20):483-94. PubMed ID: 215530
[TBL] [Abstract][Full Text] [Related]
10. Defective cell-mediated immunity in carcinoma of the prostate.
Thomas JW; Jerkins G; Cox C; Lieberman P
Invest Urol; 1976 Jul; 14(1):72-5. PubMed ID: 60303
[TBL] [Abstract][Full Text] [Related]
11. Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies.
Jondal M; Klein G
Biomedicine; 1975 Jun; 23(5):163-5. PubMed ID: 1081410
[TBL] [Abstract][Full Text] [Related]
12. Immunological function in patients operated on with small intestinal shunts for morbid obesity.
Hallberg D; Nilsson BS; Backman L
Scand J Gastroenterol; 1976; 11(1):41-8. PubMed ID: 1082628
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma.
Gunvén P; Klein G; Henle W; Henle G; Forsby N
Biomed Pharmacother; 1983; 37(1):41-4. PubMed ID: 6311307
[TBL] [Abstract][Full Text] [Related]
14. Cellular immunity in nasopharyngeal carcinoma. I. Relationship between purified protein derivative test and leukocyte migration test.
Hsu MM; Lo RJ; Lynn TC; Hsieh T; Tu SM
Taiwan Yi Xue Hui Za Zhi; 1975 Aug; 74(8):517-24. PubMed ID: 1063250
[No Abstract] [Full Text] [Related]
15. Impaired general cell-mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinoma.
Chan SH; Chew TS; Goh EH; Simons MJ; Shanmugaratnam K
Int J Cancer; 1976 Aug; 18(2):139-44. PubMed ID: 955740
[TBL] [Abstract][Full Text] [Related]
16. IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.
Ho HC; Ng MH; Kwan HC
Br J Cancer; 1977 Jun; 35(6):888-90. PubMed ID: 194619
[No Abstract] [Full Text] [Related]
17. Cell-mediated immune status of colon cancer patients: evaluation by dermal antigen testing, measurment of lymphocyte stimulation and counts of peripheral blood rosette-forming cells.
Evans JT; Goldrosen MH; Minowada J; Howell J; Mittelman A; Chu TM; Holyoke ED
Cancer; 1977 Nov; 40(5 Suppl):2716-25. PubMed ID: 303541
[No Abstract] [Full Text] [Related]
18. Serum IgA in the diagnosis of nasopharyngeal and paranasal sinus carcinoma.
Wara WM; Ammann AJ; Wara DW; Phillips TL
Radiology; 1975 Aug; 116(02):409-11. PubMed ID: 1153745
[TBL] [Abstract][Full Text] [Related]
19. Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response.
Chess L; Bock GN; Ungaro PC; Buchholz DH; Mardiney MR
J Natl Cancer Inst; 1973 Jul; 51(1):57-65. PubMed ID: 4720886
[No Abstract] [Full Text] [Related]
20. In vivo cell-mediated immunity in Chinese patients with nasopharyngeal carcinoma.
Ho JH; Chau JC; Tse KC; Ng MH; Levine PH
IARC Sci Publ (1971); 1978; (20):545-52. PubMed ID: 215533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
